SI2555789T1 - Inhibirajoči peptidi, pridobljeni iz trem podobnega transkripta 1 (TLT-1), in njih uporaba - Google Patents

Inhibirajoči peptidi, pridobljeni iz trem podobnega transkripta 1 (TLT-1), in njih uporaba

Info

Publication number
SI2555789T1
SI2555789T1 SI201131893T SI201131893T SI2555789T1 SI 2555789 T1 SI2555789 T1 SI 2555789T1 SI 201131893 T SI201131893 T SI 201131893T SI 201131893 T SI201131893 T SI 201131893T SI 2555789 T1 SI2555789 T1 SI 2555789T1
Authority
SI
Slovenia
Prior art keywords
trem
tlt
transcript
peptides derived
inhibiting peptides
Prior art date
Application number
SI201131893T
Other languages
English (en)
Inventor
Sebastien Gibot
Marc Derive
Original Assignee
Inserm (Institut National De La Sante Et De La Recherche Medicale)
Universite De Lorraine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inserm (Institut National De La Sante Et De La Recherche Medicale), Universite De Lorraine filed Critical Inserm (Institut National De La Sante Et De La Recherche Medicale)
Publication of SI2555789T1 publication Critical patent/SI2555789T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201131893T 2010-04-08 2011-04-08 Inhibirajoči peptidi, pridobljeni iz trem podobnega transkripta 1 (TLT-1), in njih uporaba SI2555789T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10305364 2010-04-08
EP11718957.1A EP2555789B1 (en) 2010-04-08 2011-04-08 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
PCT/EP2011/055519 WO2011124685A1 (en) 2010-04-08 2011-04-08 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof

Publications (1)

Publication Number Publication Date
SI2555789T1 true SI2555789T1 (sl) 2020-10-30

Family

ID=42262363

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131893T SI2555789T1 (sl) 2010-04-08 2011-04-08 Inhibirajoči peptidi, pridobljeni iz trem podobnega transkripta 1 (TLT-1), in njih uporaba

Country Status (18)

Country Link
US (2) US9255136B2 (sl)
EP (2) EP3741383A1 (sl)
JP (2) JP5918750B2 (sl)
CN (1) CN103153327B (sl)
AU (1) AU2011237851B2 (sl)
CA (1) CA2795390C (sl)
CY (1) CY1123304T1 (sl)
DK (1) DK2555789T3 (sl)
ES (1) ES2805301T3 (sl)
HR (1) HRP20201081T1 (sl)
HU (1) HUE050815T2 (sl)
LT (1) LT2555789T (sl)
NZ (1) NZ602845A (sl)
PL (1) PL2555789T3 (sl)
PT (1) PT2555789T (sl)
RS (1) RS60636B1 (sl)
SI (1) SI2555789T1 (sl)
WO (1) WO2011124685A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2892920T3 (pl) * 2012-09-07 2020-08-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Peptydy hamujące pochodzące z receptora aktywującego wykazującego ekspresję na podobnym do trem transkrypcie 1 (tlt-1) komórek szpikowych-1 (trem-1) i ich zastosowania
KR101404098B1 (ko) * 2012-11-29 2014-06-05 성균관대학교산학협력단 금속 나노와이어-유기화합물 복합체, 이를 포함하는 필름, 및 이의 제조 방법
CN108135961A (zh) * 2015-06-12 2018-06-08 台湾基督长老教会马偕医疗财团法人马偕纪念医院 调控免疫反应的方法及多肽
JOP20190248A1 (ar) 2017-04-21 2019-10-20 Amgen Inc بروتينات ربط مولد ضد trem2 واستخداماته
CN108276488B (zh) * 2018-01-26 2020-06-19 四川农业大学 一种鸡髓样细胞触发受体b2多克隆抗体及其制备方法和应用
WO2020036987A1 (en) 2018-08-13 2020-02-20 Signablok, Inc. Peptides and compositions for targeted treatment and imaging
EP3856222A1 (en) * 2018-09-28 2021-08-04 Inotrem Use of soluble trem-1 levels for identifying subjects susceptible to respond to an anti-inflammatory therapy
EP3956359A1 (en) 2019-04-17 2022-02-23 Novo Nordisk A/S Bispecific antibodies
WO2021144388A1 (en) 2020-01-15 2021-07-22 Fresenius Kabi Ipsum S.R.L. Process for the synthesis of nangibotide
WO2021231971A1 (en) * 2020-05-14 2021-11-18 Ascendo Biotechnology, Inc. Selective targeting of the treml1/md2 interaction by small peptide or protein and its use for vaccine adjuvants
CA3180293A1 (en) * 2020-06-05 2021-12-09 Marc Derive Trem-1 inhibitor for use in the treatment of a subject suffering from a coronavirus infection
CA3220167A1 (en) 2021-06-02 2022-12-08 Marc Derive Anti-trem-1 antibodies
CN113755580B (zh) * 2021-09-13 2023-10-27 中国医学科学院阜外医院 一种治疗和/或缓解淋巴水肿的药物干预靶点及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2005261A (en) 1933-05-24 1935-06-18 Leland Electric Co Riveting machine
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
ES2259800T3 (es) 1990-06-11 2006-10-16 Gilead Sciences, Inc. Procedimientos de uso de ligandos de acido nucleico.
CA2156725A1 (en) 1993-02-22 1994-09-01 Warren S. Pear Production of high titer helper-free retroviruses by transient transfection
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US7129072B1 (en) 1999-08-30 2006-10-31 New York University Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor
AU4705201A (en) * 1999-10-27 2001-06-25 Cel-Sci Corporation Peptide constructs for treating autoimmune and related diseases
JP2001210726A (ja) * 2000-01-24 2001-08-03 Hitachi Ltd 半導体装置及びその製造方法
AU6173501A (en) * 2000-05-19 2001-12-03 Blood Res Center Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
AU7494701A (en) 2000-05-23 2001-12-03 Cenes Pharmaceuticals Inc Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US20040266674A1 (en) * 2001-09-05 2004-12-30 Mills Bradley Jay Lp mammalian proteins; related reagents
US20040180409A1 (en) 2003-03-16 2004-09-16 Mcvicar Daniel TLT-1, a novel platelet-associated receptor and uses therefor
GB0426146D0 (en) * 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
WO2007132461A2 (en) 2006-05-11 2007-11-22 Ramot At Tel Aviv University Ltd. Classification of protein sequences and uses of classified proteins
US7553936B2 (en) * 2006-12-04 2009-06-30 The United States of America as represented by Secretary Department of Health and Human Services Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
WO2010132370A2 (en) 2009-05-11 2010-11-18 Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Soluble tlt-1 for the treatment and diagnosis of sepsis

Also Published As

Publication number Publication date
AU2011237851B2 (en) 2015-02-05
CA2795390C (en) 2020-11-03
LT2555789T (lt) 2020-09-25
JP5918750B2 (ja) 2016-05-18
CN103153327B (zh) 2016-01-20
DK2555789T3 (da) 2020-07-20
AU2011237851A1 (en) 2012-11-01
HRP20201081T1 (hr) 2021-01-22
JP2016169208A (ja) 2016-09-23
US9255136B2 (en) 2016-02-09
NZ602845A (en) 2015-05-29
PT2555789T (pt) 2020-07-14
EP2555789A1 (en) 2013-02-13
ES2805301T3 (es) 2021-02-11
JP2013523140A (ja) 2013-06-17
US20160015773A1 (en) 2016-01-21
PL2555789T3 (pl) 2021-02-08
WO2011124685A1 (en) 2011-10-13
US20130029921A1 (en) 2013-01-31
CY1123304T1 (el) 2021-12-31
EP2555789B1 (en) 2020-06-10
US9815883B2 (en) 2017-11-14
RS60636B1 (sr) 2020-09-30
HUE050815T2 (hu) 2021-01-28
CN103153327A (zh) 2013-06-12
CA2795390A1 (en) 2011-10-13
EP3741383A1 (en) 2020-11-25

Similar Documents

Publication Publication Date Title
SI2555789T1 (sl) Inhibirajoči peptidi, pridobljeni iz trem podobnega transkripta 1 (TLT-1), in njih uporaba
HRP20182076T1 (hr) Sustav s kontroliranim otpuštanjem koji obuhvaća glatiramer acetat
HK1208686A1 (en) Aromatic-cationic peptides and uses of same
IL248880A0 (en) Preparations containing r-g-cysteic acid peptides and their uses
IL219882A0 (en) System for increasing gene expression and vector comprising the system
EP2566880A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
EP2383283A4 (en) NOGGIN PEPTIDE AND ITS USE
EP2313498A4 (en) DETECTION SEQUENCES FOR MEGANUCLEASES FROM I-CREI AND ITS USE
EP2593595A4 (en) NOVEL PEPTIDES AND USES THEREOF
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
GB201012651D0 (en) Peptides
EP2521564A4 (en) APOE PEPTIDE DIMERS AND USES THEREOF
EP2513137A4 (en) PEPTIDES DERIVED FROM SAPOSINE-A AND USES THEREOF
EP2793921A4 (en) PEPTIDES DERIVED FROM SAPOSIN A AND USES THEREOF
EP2471553A4 (en) IMMUNOGENIC COMPOSITION WITH PEPTIDES FROM CYTOMEGALOVIRUS AND THEIR USE
PL2627668T3 (pl) Peptydy i ich zastosowanie
PL3346273T3 (pl) Nowe, pochodzące od d3 d-enancjomeryczne peptydy i ich zastosowanie
IL213026A0 (en) TNA-a INHIBITING PEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
IL225464B (en) 2nd peptides, preparations containing them and their uses
HK1168363A1 (en) Novel peptide and use thereof
EP2285827A4 (en) PEPTIDES AND ITS USE
EP2398490A4 (en) MODIFICATIONS OF PEPTIDES FROM CUPREDOXIN AND METHODS OF USE
EP2358740A4 (en) CYCLIC PEPTIDES AND USES THEREOF
IL225405A0 (en) Methods for immune modulation and systems for the treatment and/or prevention of atherosclerosis, proteins, peptides and preparations.
EP2660249A4 (en) PEPTIDE DERIVATIVE AND USE THEREOF